Bulletin
Investor Alert

Nov. 29, 2021, 11:05 a.m. EST

Monday 11/29 Insider Buying Report: SRRA, MNRO

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

Nov 29, 2021 (MarketNewsVideo.com via COMTEX) --

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.

On Wednesday, Sierra Oncology's Director, Craig A. Collard, made a $310,863 purchase of SRRA, buying 13,500 shares at a cost of $23.03 each. Sierra Oncology is trading up about 0.5% on the day Monday.

And also on Wednesday, CEO & President Michael T. Broderick bought $301,098 worth of Monro, buying 5,000 shares at a cost of $60.22 each. Before this latest buy, Broderick bought MNRO at 2 other times during the past twelve months, for a total investment of $919,292 at an average of $61.29 per share. Monro Inc is trading off about 0.1% on the day Monday.

The preceding is a transcript of the MarketNewsVideo.com video published at: http://www.marketnewsvideo.com/?id=20211120211129insiderSRRAM&mv=1 .







        http://www.marketnewsvideo.com/
        


COMTEX_397955380/2478/2021-11-29T11:04:30

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

Copyright 2021 MarketNewsVideo.com

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.